GlobalRPh RX List - Yaz
- Product / population
- Adult product-specific renal information; not a complete prescribing regimen.
- Renal measure
- CrCl, mL/min, used for the supporting study; no numeric contraindication threshold is supplied.
RX mirror: this is not independent corroboration of its underlying label. Check dated-label and formulation limitations.
Renal dosing, restrictions and evidence limits
YAZ is contraindicated in renal impairment. Its drospirenone component can increase potassium, and risk is important when renal impairment coexists with potassium-sparing treatment. The source does not provide a renal dose-reduction workaround. The YAZ regimen is not interchangeable with other drospirenone/ethinyl estradiol products.